Chloral hydrate enteral infusion for sedation in ventilated children: the CHOSEN pilot study
Open Access
- 26 November 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 21 (1), 290
- https://doi.org/10.1186/s13054-017-1879-7
Abstract
We aimed to test a novel method of delivery of chloral hydrate (CH) sedation in ventilated critically ill young children. Children < 12 years old, within 72 hours of admission, who were ventilated, receiving enteral tube-feeds, with intermittent CH ordered were enrolled after signed consent. Patients received a CH loading-dose of 10 mg/kg enterally, then a syringe-pump enteral infusion at 5 mg/kg/hour, increasing to a maximum of 9 mg/kg/hour. Cases were compared to historical controls matched for age group and Pediatric Risk of Mortality score (PRISM) category, using Fisher’s exact test and the t test. The primary outcome was feasibility, defined as the use of an enteral CH continuous infusion without discontinuation attributable to a pre-specified potential harm. There were 21 patients enrolled, at age 11.4 (12.1) months, with bronchiolitis in 10 (48%), a mean Pediatric Logistic Organ Dysfunction (PELOD) score of 6.2 (5.2), and having received enteral CH continuous infusion for 4.5 (2.2) days. Infusion of CH was feasible in 20/21 (95%; 95% CI 76–99%) patients, with one (5%) adverse event of duodenal ulcer perforation on day 3 in a patient with croup receiving regular ibuprofen and dexamethasone. The CH infusion dose (mg/kg/h) on day 2 (n = 20) was 8.9 (IQR 5.9, 9), and on day 4 (n = 11) was 8.8 (IQR 7, 9). Days to titration of adequate sedation (defined as ≤ 3 PRN doses/shift) was 1 (IQR 0.5, 2.5), and hours to awakening for extubation was 5 (IQR 2, 9). Cases (versus controls) had less positive fluid balance at 48 h (-2 (45) vs. 26 (46) ml/kg, p = 0.051), and a decrease in number of PRN sedation doses from 12 h pre to 12 hours post starting CH (4.7 (3.3) to 2.6 (2.8), p = 0.009 versus 2.9 (3.9) to 3.4 (5), p = 0.74). There were no statistically significant differences between cases and controls in inotrope scores, signs or treatment of withdrawal, or PICU days. Delivering CH by continuous enteral infusion is feasible, effective, and may be associated with less positive fluid balance. Whether there is a risk of duodenal perforation requires further study.Funding Information
- Department of Pediatrics, University of Alberta (SEED Grant)
This publication has 18 references indexed in Scilit:
- Sedation and Analgesia in the Mechanically Ventilated PatientAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPEDIATRICS, 2010
- Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass*Pediatric Critical Care Medicine, 2010
- Evidence of safety of chloral hydrate for prolonged sedation in PICU in a tertiary teaching hospital in southern BrazilEuropean Journal of Clinical Pharmacology, 2009
- Current United Kingdom sedation practice in pediatric intensive carePediatric Anesthesia, 2007
- Consensus guidelines on sedation and analgesia in critically ill childrenIntensive Care Medicine, 2006
- Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre studyThe Lancet, 2003
- Sedation and Analgesia in Paediatric Intensive Care UnitsPediatric Drugs, 1999
- A randomized controlled trial of sedation in the critically illPediatric Anesthesia, 1997
- PRISM IIICritical Care Medicine, 1996